Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report

Non‐Hodgkin lymphoma can occur concurrently with chronic phase‐chronic myeloid leukemia (CML) at initial diagnosis. Combination treatment with second‐generation tyrosine kinase inhibitors and rituximab‐CHOP for patients newly diagnosed with CML and non‐Hodgkin lymphoma is effective for both diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeyasu, Yuki, Satake, Atsushi, Azuma, Yoshiko, Tsubokura, Yukie, Yoshimura, Hideaki, Hotta, Masaaki, Nakanishi, Takahisa, Fujita, Shinya, Nakaya, Aya, Ito, Tomoki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715580/
https://www.ncbi.nlm.nih.gov/pubmed/29225854
http://dx.doi.org/10.1002/ccr3.1253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715580/
https://www.ncbi.nlm.nih.gov/pubmed/29225854
http://dx.doi.org/10.1002/ccr3.1253

Ejemplares similares